Physician profile
Juan E Gallego
NPI 1144422379
$73,154.07
in general payments reported to CMS, 2019-2025
13 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2021: $522 · 2022: $494 · 2023: $33K · 2024: $26K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Consulting Fee: $11K · Food and Beverage: $6,176 · Travel and Lodging: $444 · Education: $55.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,050.00 |
| Consulting Fee | $11,250.00 |
| Food and Beverage | $6,175.64 |
| Travel and Lodging | $444.39 |
| Education | $55.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $58,369.15 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $12,061.34 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Astrazeneca Pharmaceuticals LP | $1,177.45 | 2019-2025 | Andexxa, Airsupra |
| Pfizer INC. | $416.78 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $264.48 | 2021-2024 | Xarelto |
| Penumbra, INC. | $244.85 | 2022-2023 | Indigo System |
| Medtronic, INC. | $220.63 | 2024 | Micra, Kyphon Express II Kyphopak Tray |
| Alexion Pharmaceuticals, INC. | $137.68 | 2021-2022 | |
| Vifor Pharma, INC. | $122.40 | 2021 | |
| Angiodynamics, INC. | $56.59 | 2019 | |
| Abbott Laboratories | $47.81 | 2025 | I-Stat |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Livanova USA, INC. | $14.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Gallego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.